Martin Wilson
Known title: General CounselCIK: 0001704342
Associated companies
Transaction History
| RCKT | ▼ Sell | Open Market | 75,364 | $256K | 9/11/2026 | View on chart |
| RCKT | ▼ Sell | Open Market | 631 | $2K | 8/18/2026 | View on chart |
| RCKT | ▼ Sell | Open Market | 3,493 | $12K | 8/13/2026 | View on chart |
| RCKT | ▼ Sell | Open Market | 662 | $2K | 5/19/2026 | View on chart |
| RCKT | ▼ Sell | Open Market | 3,361 | $12K | 5/13/2026 | View on chart |
| RCKT | ▼ Sell | Open Market | 1,376 | $5K | 2/18/2026 | View on chart |
| RCKT | ▼ Sell | Open Market | 12,253 | $41K | 2/13/2026 | View on chart |
| RCKT | ▲ Buy | Grant | 311,813 | $0 | 2/11/2026 | View on chart |
| RCKT | ▼ Sell | Open Market | 1,646 | $5K | 11/18/2025 | View on chart |
| RCKT | ▲ Buy | Grant | 100,000 | $0 | 11/3/2025 | View on chart |
| RCKT | ▲ Buy | Grant | 150,000 | $0 | 9/8/2025 | View on chart |
| RCKT | ▼ Sell | Open Market | 588 | $2K | 8/19/2025 | View on chart |
| RCKT | ▼ Sell | Open Market | 1,004 | $3K | 8/18/2025 | View on chart |
| RCKT | ▼ Sell | Open Market | 12,109 | $37K | 8/14/2025 | View on chart |
| RCKT | ▼ Sell | Open Market | 587 | $4K | 5/20/2025 | View on chart |
| RCKT | ▼ Sell | Open Market | 946 | $6K | 5/16/2025 | View on chart |
| RCKT | ▼ Sell | Open Market | 3,222 | $34K | 2/21/2025 | View on chart |
| RCKT | ▲ Buy | Grant | 90,358 | $0 | 2/11/2025 | View on chart |
| RCKT | ▼ Sell | Open Market | 1,175 | $15K | 11/21/2024 | View on chart |
| RCKT | ▼ Sell | Open Market | 1,027 | $19K | 8/16/2024 | View on chart |
| RCKT | ▼ Sell | Open Market | 1,048 | $24K | 5/16/2024 | View on chart |
| RCKT | ▲ Buy | Option Exercise | 2,420 | $0 | 5/14/2024 | View on chart |
| RCKT | ▼ Sell | Open Market | 4,100 | $120K | 2/29/2024 | View on chart |
| RCKT | ▼ Sell | Open Market | 3,576 | $107K | 2/16/2024 | View on chart |
| RCKT | ▲ Buy | Grant | 16,644 | $0 | 2/16/2024 | View on chart |
| RCKT | ▲ Buy | Option Exercise | 9,712 | $0 | 2/14/2024 | View on chart |
| RCKT | ▼ Sell | Other | 16,947 | $0 | 2/14/2023 | View on chart |
| RCKT | ▼ Sell | Other | 28,763 | $0 | 8/12/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Rocket Pharmaceuticals Gets FDA Alignment on Heart Drug Trial
Rocket Pharmaceuticals has secured FDA alignment on a trial for its heart drug, which may help address prior safety concerns. This regulatory step is significant for the company's development timeline. The stock is currently trading near its 52-week low, reflecting ongoing market caution despite this progress.
Rocket Pharmaceuticals Gets FDA Alignment on Heart Drug Trial. Rocket Pharmaceuticals has secured FDA alignment on a trial for its heart drug, which may help address prior safety concerns. This regulatory step is significant for the company's development timeline. The stock is currently trading near its 52-week low, reflecting ongoing market caution despite this progress.